Edwards Lifesciences Corp [EW] stock prices are up 0.34% to $65.37 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The EW shares have lost -0.61% over the last week, with a monthly amount drifted -5.16%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Edwards Lifesciences Corp [NYSE: EW] stock has seen the most recent analyst activity on September 18, 2024, when Jefferies downgraded its rating to a Hold and also revised its price target to $70 from $85. Previously, Daiwa Securities upgraded its rating to Outperform on July 31, 2024. On July 29, 2024, upgrade upgraded it’s rating to Peer Perform. Truist downgraded its rating to a Hold and decreased its price target to $82 on July 25, 2024. TD Cowen downgraded its rating to a Hold and reduced its price target to $70 on July 25, 2024. Robert W. Baird downgraded its rating to Neutral for this stock on July 25, 2024, and downed its price target to $70. In a note dated July 25, 2024, JP Morgan downgraded an Neutral rating on this stock and revised its target price from $105 to $72.
The stock price of Edwards Lifesciences Corp [EW] has been fluctuating between $58.93 and $96.12 over the past year. Currently, Wall Street analysts expect the stock to reach $94.14 within the next 12 months. Edwards Lifesciences Corp [NYSE: EW] shares were valued at $65.37 at the most recent close of the market. An investor can expect a potential return of 44.01% based on the average EW price forecast.
Analyzing the EW fundamentals
The Edwards Lifesciences Corp [NYSE:EW] reported sales of 6.00B for trailing twelve months, representing a drop of -9.43%. Gross Profit Margin for this corporation currently stands at 0.77% with Operating Profit Margin at 0.27%, Pretax Profit Margin comes in at 0.28%, and Net Profit Margin reading is 0.25%. To continue investigating profitability, this company’s Return on Assets is posted at 0.15, Equity is 0.21 and Total Capital is 0.18. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 64.29 points at the first support level, and at 63.20 for the second support level. However, for the 1st resistance point, the stock is sitting at 66.25, and for the 2nd resistance point, it is at 67.12.
Ratios To Look Out For
It’s worth pointing out that Edwards Lifesciences Corp [NYSE:EW]’s Current Ratio is 3.71. On the other hand, the Quick Ratio is 2.87, and the Cash Ratio is 1.35. Considering the valuation of this stock, the price to sales ratio is 6.56, the price to book ratio is 5.29 and price to earnings (TTM) ratio is 26.90.
Transactions by insiders
Recent insider trading involved BOBO DONALD E JR, CVP,Strategy/Corp Development, that happened on Sep 11 ’24 when 5000.0 shares were sold. CVP, TMTT, Chopra Daveen completed a deal on Aug 20 ’24 to sell 1250.0 shares. Meanwhile, Officer Chopra Daveen bought 1250.0 shares on Aug 20 ’24.
